Zebrafish Models of Neurodevelopmental Disorders: Past, Present, and Future

被引:102
|
作者
Sakai, Catalina [1 ]
Ijaz, Sundas [1 ]
Hoffman, Ellen J. [1 ,2 ]
机构
[1] Yale Univ, Ctr Child Study, Program Neurogenet, Yale Sch Med, New Haven, CT 06520 USA
[2] Yale Univ, Dept Neurosci, Yale Sch Med, New Haven, CT 06520 USA
来源
基金
美国国家卫生研究院;
关键词
zebrafish; neurodevelopmental disorders; autism spectrum disorders; epilepsy; schizophrenia; model system; genetics; neural circuits; WHOLE-BRAIN ACTIVITY; AUTISM SPECTRUM DISORDER; TARGETED GENE DISRUPTION; DE-NOVO MUTATIONS; LOCOMOTOR-ACTIVITY; REVERSE GENETICS; GENOME-WIDE; KNOCK-IN; EPILEPSY; 16P11.2;
D O I
10.3389/fnmol.2018.00294
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Zebrafish are increasingly being utilized as a model system to investigate the function of the growing list of risk genes associated with neurodevelopmental disorders. This is due in large part to the unique features of zebrafish that make them an optimal system for this purpose, including rapid, external development of transparent embryos, which enable the direct visualization of the developing nervous system during early stages, large progenies, which provide considerable tractability for performing high-throughput pharmacological screens to identify small molecule suppressors of simple behavioral phenotypes, and ease of genetic manipulation, which has been greatly facilitated by the advent of CRISPR/Cas9 gene editing technologies. This review article focuses on studies that have harnessed these advantages of the zebrafish system for the functional analysis of genes that are strongly associated with the following neurodevelopmental disorders: autism spectrum disorders (ASD), epilepsy, intellectual disability (ID) and schizophrenia. We focus primarily on studies describing early morphological and behavioral phenotypes during embryonic and larval stages resulting from loss of risk gene function. We highlight insights into basic mechanisms of risk gene function gained from these studies as well as limitations of studies to date. Finally, we discuss advances in in vivo neural circuit imaging in zebrafish, which promise to transform research using the zebrafish model by illuminating novel circuit-level mechanisms with relevance to neurodevelopmental disorders.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Cancer mouse models: Past, present and future
    Khaled, Walid T.
    Liu, Pentao
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2014, 27 : 54 - 60
  • [22] COMPREHENSIVE TRANSPORTATION MODELS - PAST, PRESENT AND FUTURE
    LEWIS, S
    COOK, P
    MINC, M
    TRANSPORTATION QUARTERLY, 1990, 44 (02): : 249 - 265
  • [23] Pesticide leaching models - past, present and future
    Travis, KZ
    BCPC CONFERENCE: PESTS & DISEASES 2000, VOLS 1-3, PROCEEDINGS, 2000, 1-3 : 69 - 76
  • [24] Mouse models of ALS: Past, present and future
    Lutz, Cathleen
    BRAIN RESEARCH, 2018, 1693 : 1 - 10
  • [25] Zebrafish in neurodevelopmental disorders studies: Genetic models and pathological involvement of microglia
    Nia, Fatemeh Hassani
    Wittamer, Valerie
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2025,
  • [26] Zebrafish Models of Neurodevelopmental Disorders: Limitations and Benefits of Current Tools and Techniques
    Vaz, Raquel
    Hofmeister, Wolfgang
    Lindstrand, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06)
  • [27] Functional imaging in neurodegenerative disorders: past, present and future
    Pagani, M.
    Sonni, I.
    Capriotti, G.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 58 (04): : 329 - 331
  • [28] European guidelines for personality disorders: past, present and future
    Sebastian Simonsen
    Anthony Bateman
    Martin Bohus
    Henk Jan Dalewijk
    Stephan Doering
    Andres Kaera
    Paul Moran
    Babette Renneberg
    Joaquim Soler Ribaudi
    Svenja Taubner
    Theresa Wilberg
    Lars Mehlum
    Borderline Personality Disorder and Emotion Dysregulation, 6
  • [29] The discovery of drugs for psychiatric disorders: past, present and future
    Whiting, PJ
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A3 - A3
  • [30] Past, Present and Future in the Treatment of Major Psychotic Disorders
    Fountoulakis, Konstantinos N.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (12) : 1557 - 1557